Research keywords (5):
oxaliplatin
, exosome
, resistance
, microRNA
, cancer
Research theme for competitive and other funds (2):
2022 - 2027 Molecular mechanism and chemoprevention of cholangiocarcinoma induced by liver flukes in Thailand and China
2019 - 2021 Study to the enhancement and non-invasive effect prediction of the cancer chemotherapy using miRNA
Papers (11):
Shota Tanaka, Mika Hosokawa, Ai Tatsumi, Shiho Asaumi, Ryoji Imai, Ken-ichi Ogawara. Improvement of resistance to oxaliplatin by vorinostat in human colorectal cancer cells through inhibition of Nrf2 nuclear translocation. Biochemical and Biophysical Research Communications. 2022. 607. 9-14
Shota Tanaka, Mika Hosokawa, Takumi Miyamoto, Aiko Nakagawa, Mika Haruna, Kumiko Ueda, Seigo Iwakawa, Ken-ichi Ogawara. miR-33a-5p in small extracellular vesicles as non-invasive biomarker for oxaliplatin sensitivity in human colorectal cancer cells. Biochemistry and Biophysics Reports. 2021. 26. 100996-100996
THE ACADEMY OF PHARMACEUTICAL SCIENCE AND TECHNOLOGY, JAPAN
, JAPANESE SOCIETY OF PHARMACEUTICAL HEALTH CARE AND SCIENCES
, THE JAPANESE SOCIETY FOR THE STUDY OF XENOBIOTICS
, THE PHARMACEUTICAL SOCIETY OF JAPAN